Home > Financial Ratios > AARTI PHARMALABS

AARTI PHARMALABS
EV/Core EBITDA

    Back to All Ratios
AARTI PHARMALABS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for AARTI PHARMALABS
Please provide your vote to see the results

AARTI PHARMALABS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 15.8815.1210.707.811.22

What is the latest EV/Core EBITDA ratio of AARTI PHARMALABS ?

The latest EV/Core EBITDA ratio of AARTI PHARMALABS is 15.88 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202615.88
Mar202515.12
Mar202410.70
Mar20237.81
Mar20221.22

How is EV/Core EBITDA of AARTI PHARMALABS Trending?

Years EV/Core EBITDA % Change
Mar2026 15.88
5.03
Mar2025 15.12
41.31
Mar2024 10.7
37.00
Mar2023 7.81
540.16
Mar2022 1.22 -

Other Financial Ratios of AARTI PHARMALABS


Compare EV/Core EBITDA ratio of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹8,516.3 Cr 13.8% 11.9% 4.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,717.0 Cr 1% -3.3% 13.1% Stock Analytics
DIVIS LABORATORIES ₹255,115.0 Cr 2.6% 10.8% 57.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,613.0 Cr 2.7% 0.3% 39.6% Stock Analytics
CIPLA ₹112,876.0 Cr 2.4% -1.1% -12.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,395.0 Cr 2.5% 0.8% -8.5% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

13.8%

11.9%

4.4%

SENSEX

-1%

-4.9%

-11%


You may also like the below Video Courses